Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
about
Pharmacogenetics of healthy volunteers in Puerto RicoNeurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic reviewRole of folate status and methylenetetrahydrofolate reductase genotype on the toxicity and outcome of induction chemotherapy in children with acute lymphoblastic leukemia.Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review.Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.Repairing effects of interleukin 11 (IL-11) towards high dose methotrexate-induced rat small intestinal mucositis and its impacts on T-lymphoblastic leukemia cell lineRepairing effects of interleukin 11 (IL-11) towards high dose methotrexate-induced rat small intestinal mucositis and its impacts on T-lymphoblastic leukemia cell line.Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.Pharmacogenetics of childhood acute lymphoblastic leukemia.A case of recurrent pancytopenia in a patient with acute promyelocytic leukemia on maintenance chemotherapy and concomitant methyltetrahydrofolate reductase and thiopurine S-methyltransferase mutation - review of literature.Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis.Monitoring and Treatment of Acute Kidney Injury in Children with Acute Lymphoblastic Leukemia After High Dose Methotrexate Chemotherapy.Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate.Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis.The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.Folic acid, one-carbon metabolism & childhood cancer.Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in ChinaAssociation of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis
P2860
Q26779038-2EBB754F-6303-4F45-AF11-9F2600287CD2Q28084550-339FD104-2144-49B6-86E3-E03C93F9C484Q33416747-554D94F3-9D6A-400F-A9FA-8B414780F191Q33557148-E1F58AA4-A116-484A-816F-F03E2A8C7362Q33716494-8CBDE44E-9814-442B-A128-7F498100DBC3Q34336668-87988919-9ADB-42BB-8446-5D912C9694F3Q35135954-94544722-A15E-4C37-A5E4-2E5A955A0D66Q36003451-DDE32E35-09D2-4F5C-929D-2C5990DF9FB3Q36365599-42075736-529E-420F-A13E-BB7DF5C99619Q37231108-8A62ED2E-3A76-4078-BEF4-A6559617F54BQ37306930-EEFB3823-439D-496F-AC6D-3CE35A897EC6Q37659020-A8816C50-37C9-48AE-819F-F5757A63AC2EQ38063197-39DD96B3-C3E9-4CCF-8674-7D83BBF8562CQ38243175-EB90FA75-AE03-4506-997B-3CF741905958Q38384376-DF88ACF0-D737-4C6A-8075-6C8284A03014Q38506522-2FCCA767-018C-4BBE-BBED-5290C223279AQ38824755-94AFC189-E3AA-4CCB-95DA-B0FE4189C512Q38895172-487F181F-2D36-49AB-B107-0C7803B8CBB0Q39230513-CB82A04C-A7D4-4B66-9E36-031F65CEDAB6Q39330126-43254759-1174-4C1D-A3B6-109D7D035F54Q39704809-D06431D8-E250-44A6-98D7-9F7A241395AFQ42110547-5A9D680F-0562-4871-9376-963E5069130AQ43661173-159103BC-28BA-4702-87BF-E79E4A090A2FQ43716583-CB6DE709-E29B-4D4B-B476-BB16BEFA48A9Q49088868-CE5A63A1-4E80-4806-B8A4-EAA4BE175C64Q49627883-C809013A-2108-41FF-82CE-4F7B59C3A384Q53581480-DCCFD1BB-9E9A-4C94-AB66-7D9E6BA1AFCFQ56518068-A0D7D856-5F51-4E88-968E-790016FAEFC0Q57330325-30B1896F-9934-4FB4-807C-2A7C5772B0B9
P2860
Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of methylenetetrahydrof ...... tic leukemia: a meta-analysis.
@en
type
label
Impact of methylenetetrahydrof ...... tic leukemia: a meta-analysis.
@en
prefLabel
Impact of methylenetetrahydrof ...... tic leukemia: a meta-analysis.
@en
P2093
P2860
P1433
P1476
Impact of methylenetetrahydrof ...... tic leukemia: a meta-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-012-0395-2
P577
2012-04-20T00:00:00Z
P6179
1024620530